title: DRD3, but not BDNF, genotype affects treatment response to paroxetine in major depressive disorder: a preliminary study.
authors.forename: Shoko
authors.initials: S
authors.lastname: Tsuchimine
authors.forename: Norio
authors.initials: N
authors.lastname: Yasui-Furukori
authors.forename: Taku
authors.initials: T
authors.lastname: Nakagami
authors.forename: Yasushi
authors.initials: Y
authors.lastname: Sato
authors.forename: Sunao
authors.initials: S
authors.lastname: Kaneko
mesh_terms: D019208:Brain-Derived Neurotrophic Factor / Q000235:genetics; D003865:Major Depressive Disorder / Q000188:drug therapy* / Q000235:genetics; D005838:Genotype; D006801:Humans; D017374:Paroxetine / Q000627:therapeutic use*; D010597:Pharmacogenetics; D020641:Polymorphism, Single Nucleotide; D050637:Receptors, Dopamine D3 / Q000235:genetics*; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D019208:Brain-Derived Neurotrophic Factor; D017374:Paroxetine; D050637:Receptors, Dopamine D3; D017367:Selective Serotonin Reuptake Inhibitors; C493593:DRD3 protein, human